These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 8701182)

  • 1. [Assessment of ventricular arrhythmias].
    Osswald S; Rickenbacher P; Buser PT; Pfisterer M
    Praxis (Bern 1994); 1996 Feb; 85(7):179-87. PubMed ID: 8701182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic therapy for ventricular arrhythmias.
    Zimmermann M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S59-64. PubMed ID: 1723121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ventricular arrhythmias and sudden cardiac death].
    Abuladze GV; Nevieridze MI; Abashidze RI; Gabarashvili LV; Kvirkveliia AA
    Georgian Med News; 2009 Mar; (168):50-3. PubMed ID: 19359720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of implantable loop recorders for diagnosing unexplained syncope in 100 consecutive patients: five-year, single-center experience.
    Inamdar V; Mehta S; Juang G; Cohen T
    J Invasive Cardiol; 2006 Jul; 18(7):313-5. PubMed ID: 16816436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches to evaluation and management of patients with ventricular arrhythmias.
    Buxton AE; Kirk MM; Michaud GF
    Med Health R I; 2001 Feb; 84(2):58-62. PubMed ID: 11272662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antiarrhythmic agents for ventricular arrhythmias.
    Meissner MD; Nestico PF; Morganroth J
    Clin Ther; 1986; 8(6):595-604. PubMed ID: 3539346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
    Dorian P; Newman D; Greene M
    Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of chronic ventricular arrhythmias.
    Khan AH
    Am Fam Physician; 1994 Jun; 49(8):1805-11. PubMed ID: 8203318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.